DE69629691D1 - Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen - Google Patents

Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen

Info

Publication number
DE69629691D1
DE69629691D1 DE69629691T DE69629691T DE69629691D1 DE 69629691 D1 DE69629691 D1 DE 69629691D1 DE 69629691 T DE69629691 T DE 69629691T DE 69629691 T DE69629691 T DE 69629691T DE 69629691 D1 DE69629691 D1 DE 69629691D1
Authority
DE
Germany
Prior art keywords
positive bacteria
treating infections
resistant gram
antibiotic
controlling antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629691T
Other languages
English (en)
Other versions
DE69629691T2 (de
Inventor
Peter Blackburn
P Goldstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMBI Inc
Original Assignee
AMBI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AMBI Inc filed Critical AMBI Inc
Application granted granted Critical
Publication of DE69629691D1 publication Critical patent/DE69629691D1/de
Publication of DE69629691T2 publication Critical patent/DE69629691T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69629691T 1995-06-23 1996-06-21 Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen Expired - Lifetime DE69629691T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43595P 1995-06-23 1995-06-23
US435P 1995-06-23
PCT/US1996/010756 WO1997000694A1 (en) 1995-06-23 1996-06-21 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Publications (2)

Publication Number Publication Date
DE69629691D1 true DE69629691D1 (de) 2003-10-02
DE69629691T2 DE69629691T2 (de) 2004-02-26

Family

ID=21691527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629691T Expired - Lifetime DE69629691T2 (de) 1995-06-23 1996-06-21 Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen

Country Status (18)

Country Link
US (1) US5866539A (de)
EP (1) EP0833657B1 (de)
JP (1) JP4236699B2 (de)
KR (1) KR19990028283A (de)
CN (1) CN1138560C (de)
AT (1) ATE247973T1 (de)
AU (1) AU713050B2 (de)
BR (1) BR9609281A (de)
CA (1) CA2225530C (de)
CZ (1) CZ290578B6 (de)
DE (1) DE69629691T2 (de)
ES (1) ES2201189T3 (de)
IL (2) IL122248A0 (de)
NO (1) NO976028D0 (de)
NZ (1) NZ311535A (de)
RU (1) RU2202360C2 (de)
SK (1) SK285563B6 (de)
WO (1) WO1997000694A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
EP1212006B1 (de) * 1999-08-31 2006-02-22 Gore Enterprise Holdings, Inc. Verbesserte zahnseide mit niedriger dichte
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
AU2003296937A1 (en) * 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
ES2436614T3 (es) 2005-07-28 2014-01-03 Biosynexus Incorporated Composiciones y procedimientos de tratamiento de bacterias
US7576054B2 (en) * 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
WO2007092582A2 (en) * 2006-02-08 2007-08-16 Biosynexus Incorporated Neutralization of bacterial spores
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
RU2506272C2 (ru) * 2008-11-24 2014-02-10 Сентинелла Фармасьютикалз, Инк. ("Сентинелла") Лантибиотические карбоксиамидные производные с усиленной антибактериальной активностью
KR101107764B1 (ko) * 2009-01-05 2012-01-20 박세준 항 유해균 기능을 가진 에스제이피미생물
EP2387580B1 (de) 2009-01-14 2014-08-13 Novacta Biosystems Limited Deoxyactagardinderivate
JP5731407B2 (ja) 2009-02-04 2015-06-10 ノヴァクタ バイオシステムズ リミティッド アクタガルジン誘導体
EP2405742A2 (de) * 2009-03-11 2012-01-18 CryoLife, Inc. Biobelastungsreduzierende antibiotikazusammensetzung und verfahren zu ihrer verwendung
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
US8475827B2 (en) 2010-07-06 2013-07-02 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
RU2638814C1 (ru) * 2016-09-27 2017-12-15 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Способ профилактики инфекционных осложнений бактериальной природы после операции на сердце, проведенной в условиях искусственного кровообращения
CN108982430B (zh) * 2017-05-31 2020-09-29 北京大学 标记细菌菌群样品的试剂盒、方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
NZ311535A (en) 2001-05-25
AU6289196A (en) 1997-01-22
JP4236699B2 (ja) 2009-03-11
WO1997000694A1 (en) 1997-01-09
KR19990028283A (ko) 1999-04-15
EP0833657B1 (de) 2003-08-27
CN1138560C (zh) 2004-02-18
AU713050B2 (en) 1999-11-25
RU2202360C2 (ru) 2003-04-20
JPH11508265A (ja) 1999-07-21
IL122248A0 (en) 1998-04-05
NO976028L (no) 1997-12-22
US5866539A (en) 1999-02-02
ATE247973T1 (de) 2003-09-15
DE69629691T2 (de) 2004-02-26
CZ290578B6 (cs) 2002-08-14
NO976028D0 (no) 1997-12-22
IL122248A (en) 2009-09-01
CZ402597A3 (cs) 1998-09-16
SK285563B6 (sk) 2007-03-01
SK172697A3 (en) 1998-12-02
BR9609281A (pt) 1999-06-15
CA2225530A1 (en) 1997-01-09
CA2225530C (en) 2002-08-20
CN1188415A (zh) 1998-07-22
EP0833657A1 (de) 1998-04-08
ES2201189T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
DE69629691D1 (de) Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
DE69834339D1 (de) Verwendung einer zusammensetzung die einen chelatbildner und eine antimikrobielle verbindung enthaltet zur behandlung von biofilmen
CY1108437T1 (el) Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
BR9507099A (pt) Forma de dosagem método de esterilização composição esterilizante e suplemento alimentar animal compreendendo nitrito acidificado como um agente anti-microbiano
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE231686T1 (de) Schädlingsbekämpfungsmittel zur behandlung von saatgut
RU93004457A (ru) 1-карба-(1-детиа)-цефемы и промежуточные продукты для их получения
ATE180944T1 (de) Tuberkilizide synergistische desinfizierende zusammensetzung und verfahren zur desinfektion
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DE69415515T2 (de) Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE359816T1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
DE69305886T2 (de) Verfahren zur bakteriellen Behandlung von mit Flora verschmutzten Kreisläufen der Papierindustrie
AR013480A1 (es) 9a-azalidas como agentes antimicrobicos veterinarios
DE69827814D1 (de) 8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
DE69716056T2 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
ATE308895T1 (de) Behandlung von infektionen in tieren
ATE145828T1 (de) Verfahren zur desinfektion von muskelskelettgeweben und so aufbereitete gewebe
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére
DE60222298D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης
DE69112718D1 (de) Verfahren und Zusammensetzung zur Behandlung von tierischen Exkrementen.
BR9611759A (pt) Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano